Location History:
- Shanghai, CN (2008)
- Shanghai, JP (2017)
Company Filing History:
Years Active: 2008-2017
Title: Guoliang Xu: Innovator in Leukemia Therapeutics
Introduction
Guoliang Xu is a prominent inventor based in Shanghai, Japan. He has made significant contributions to the field of leukemia research, particularly through his innovative patents. With a total of 2 patents, Xu's work focuses on identifying therapeutic agents for leukemia.
Latest Patents
Xu's latest patents include groundbreaking inventions related to DOT1 histone methyltransferases. These inventions provide polypeptides with histone H3 lysine 79 methyltransferase activity, as well as nucleic acids encoding the same. The patents also outline methods for using these polypeptides and nucleic acids in screening assays to identify compounds of interest. Furthermore, they offer diagnostic methods for leukemia and prognostic methods to predict the course of the disease in a subject.
Career Highlights
Guoliang Xu is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance his research in the field of leukemia. His work has garnered attention for its potential impact on therapeutic strategies and patient outcomes.
Collaborations
Xu collaborates with notable colleagues, including Yi Zhang and Qin Feng, who contribute to his research endeavors.
Conclusion
Guoliang Xu's innovative work in leukemia therapeutics highlights his commitment to advancing medical science. His patents and research have the potential to significantly improve diagnostic and treatment options for leukemia patients.